Skip to main content

CITIGROUP INC

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 831001 NEW YORK, NY

Position in RIGL

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$1,273,981
+$1,144,163 QoQ
Shares Held
32,566
+578.3% QoQ
Ownership
0.174%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RIGL Over Time

Shares Held

Position Value (USD)

Derivatives in RIGL

reported options exposure · as of Mar 31, 2022
CallValue
$149,500
CallShares
5,000
PutValue
$149,500
PutShares
5,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. RIGL ranks #131 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RIGL

Export CSV
35 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,273,981 32,566
2026-03-31 $129,818 4,801
2025-12-31 $308,418 7,201
2025-09-30 $108,644 3,835
2025-06-30 $220,338 11,764
2025-03-31 $542,793 30,172
2024-12-31 $249,860 14,855
2024-09-30 $216,115 13,357
2024-06-30 $34,935 4,250
2024-03-31 $48,040 32,460
2023-12-31 $40,718 28,082
2023-09-30 $105 99
2023-06-30 $65,762 50,979
2023-03-31 $163,760 124,061
2022-12-31 $34,880 23,254
2022-09-30 $40,374 34,216
2022-06-30 $1,777,513 1,573,021
2022-03-31 $149,500 50,000
2022-03-31 $149,500 50,000
2022-03-31 $297,322 99,439
2021-12-31 $1,087,814 410,496
2021-09-30 $779,183 214,651
2021-06-30 $2,774,184 639,213
2021-03-31 $2,650,636 775,040
2020-12-31 $4,200 1,200
2020-12-31 $771,907 220,545
2020-09-30 $7,920 3,300
2020-09-30 $25,200 10,500
2020-09-30 $46,233 19,264
2020-06-30 $7,137 3,900
2020-06-30 $117,903 64,428
2020-06-30 $3,660 2,000
2020-03-31 $134,740 86,372
2020-03-31 $156 100
2020-03-31 $6,084 3,900